VEGFA and neoplasm: Previous preclinical studies reported that inhibition of the VEGF pathway controlled tumor growth and inhibited the infiltration of immune suppressive cells, such as regulatory T cells, tumor-associated macrophages, and myeloid-derived suppressor cells, while it increased the mature dendritic cell fraction [80].